CASTEI FROMA IIEURO CARE IIMITED
IA COMPANY UMITED BY GUARANTEEI
REPORT A14D FINAIICIAi STATEMEpif5
FOR ThE YEAR ENDED 31 MARCH 2025
CHARITY NUMBER IIOO%S
COMPAP4Y NUMBÉR 04777559

CASTEL FROMA NEURO CARE UMITED
(a COM￿nY limtted by ￿￿•￿eel
REPORT ANO FIP4ANCIAL sfATEMEPIIS
FOR YEAR ENDED 31 MARCH 2025
Cofitents
Cha1rf5 reFhNt
Trustees, annual fe
Auditors. report
11>12
Staiemeni of flnancial a¢tfvrt*s
8alarKe sheet
14
Statement of casmows
1>16
Notes to the Ilnancsal ststen*nts
17-27

CASTEI FROMA NEURO CARE LIMITED
la c¥*npany Umlted ty ow•rteel
Castel Frtyna Neuro Cère Limited is è charitstAe compary limrted by 8uarantee operatiffd two Ca￿ ¢efit￿$ in South
Warwickshlre, Lillin8ton House and Helen Ley House. From these two kncatK*ns the charlty provided qualrty treatmenl.
rehabilltatlon and therapeutic facillties fof people wlth complex CondIt￿n$ ranglngfrom braln Inlurlesto rnuttlple xleroys.
motor neurone. Parkinson's and Hunbngton's diseases.
Providing care at the level our reydents need is expEn5Ne. We achieved an ir￿orne in the fi.￿ar￿￿1 year 2024-25 of £9 rnlllion,
predominantw from fees paid by the NHS and othef wllic sector atKI sources. Thi5 xjm akn indudes donatK)ns and
8ac*s of mfe ihan E90,LYJJ.
The healihtsre sertor In the UK remains under C¢)nsiderable financsal pressure. Engurln8 our residents remain appropriately
funded is an ongoing challenge at a when we fao considerable Tlsing operatln8 costs. in fee In(fea￿ to reflect
increased costs ￿ to a delKrt lof rhe year of ft￿re than £5￿.￿. The trustees and management are drfermined 10 stem
opeTating at a ddKiL We are wrSUi￿ a stTate8y of working towards fea115tK fee I￿e15 whilst also ensuring that costs are
actbvety managed.
The year WaS￿ry busy. a￿1 f(xussed on achievir¥ our 8oal of continuing to provide a ￿l￿rnnt and essentkil service. In •lu8Urt
2024 we beean a revlew of CKbr servkes to erisure that our alÈns to resKlent needs and furthr exFertations, deiails
of whth can be found on our websrte: h
restoratlon-
rEventiO￿an0-
-of-lrte
In iaNary 2025The Cao (lualltycomrrtssbn appffjval for the chartfy￿ start a net**lycornpleted extenslon at Helen
Ley House compri*ng of e￿￿t new rooms. all with ensuite facilrtva. Tr* review and creatjon of more capaclty at Helen Ley
House cC￿l￿ned. enabled rhe Trusrees ro make the declsvl In Felyuary 202S to sell an ègeln8 pan rhe Llllington House s
that is costty to mainlain arKI outdated for our needs.
Ca5tel Froma Neuro ca￿ Limrted anticipate5 that the Sa￿ will help the charrty to generate fund5 to laurKh new ser￿￿e$. wrth
r*w'community hub. in retained grounds at LiW¥won House sr(e, where patients Ipiing wrth neuro*Kèl condriiDns and
brain injur*5 in the communrty ¢an Tr￿le easity a¢¢e55 serykes. Further details can be fwnd on the chanty'5 website:
htt
af(h<hari
mmuni
ac
The work ot the charity Is only made posslble by the efforts and good*ryll of the staff and also rnany Indfvlduals who
give their time freely in many different ways to offer support. Thls is very much appreciated. Firtally, I wish io thank
my fellow trustees foi ther continued dedicatth ènd yJH￿rt of Castel Frryna Neuro ca￿ Lynrted.
Caroline Wilson
Chair of Trusiees
23 Oecember 202S

CASTEI FROMA NEURO CARE LIMITED
la c¥*npany Umlted ty ow•rteel
TRusfEES' ANNUAL REPORT (Inck￿￿$ Dirertots. and Str•trfK Rewt)
FOR THE YEAR ENDED 31 MARCH 21ll5
trustees are pleased to present tt*ir annual ￿pOrt together wrth the audrted financial statements ol the chanty tor the
vear ended 31 March 202S. which are also prepared to meet the requirements for the strateglc and directOfS' fewrt and
accounts for Companies Act purp0525 The financial statements have been prepored in accordance with the accountlll8
Jlitles set out In tht notes to the ￿cOUrtS and compfy wrth tht charitVs governing document. the Charitles Act 2011 and
Reportin8 by Charilies= Statement ol Recommended Practte applicab￿ to charrtles preparin8 their accounts In a¢¢ordance
with the Fina￿la1 Rep)rting Standard applicable in the UK and Republic of Ireland published in Ottober 2019.
On l April 2011 Castel Froma las the chartty was then known) merged wtth Royal Midland Counties Home for the
Disabled. a charity under common control. Royal Midland Coynties Home for the Disabled remains a separate charity.
placed under a Uniting Direction with Casiel Froma. On l April 2011 the expendable assets of Royal Midland Counties
Home for the Disabled were trèrbsferred to Castel Froma and the perrnènent endowment Wa5 placed under the
protectlon of the Trustees of Castel Froma. The following financial statements report the combined ptrformance and
financial position of Castel Froma and Royal Midland Counties Home for the Disabled.
Reference administrati* wrf0m￿l•0n
Castel Froma Neuro ca￿ Limited:.
Registered charity number
Registered company Nrnber
lIC￿5
04777559
Country of incorporatlon
E￿land
Royal Midland Countie5 Home for the
Disabled registered charny wml
(Linked charrtyl
IiC(86>1
Re8iStered office
93 Lillington Road
Leamington Spa
W•v*4irk5hire
C4132 6LL
Audltors
HB&O Ltd
Chartered Accountanls and Statutory Audlttsr
Highdown House.
11 Hi8hdown R¢)ad
Leamington Spa
C431 Ixr
8anke
Lbyds 8ank
73 The Parade
Leamiwon Spa
CV32 488
SolkrtOf5
HCR Wrlght Ha55all LLP
Otympus Avenue
Leamin8ton Spa
Cd34 6BF
HCR Legal LLP
Ellenborough House
Wellington Street
Cheltenham
Gi50 IYO

CASTEI FROMA NEURO CARE LIMITED
la c¥*npany Umlted ty ow•rteel
TRLisfEES' ANf4VAL REPORT (cortirn*d)
FOR THE YEAR ENDED 31 MARCH 21ll5
Olrnctorn and trurttts and dlkl•ls
President
Parron
e-presidert
12th Ead of Aylesford
Mr T Cox. Her Majest￿$ Lord ￿'eutenant of Warwkkshire
Mr5 D DOw(￿Swe11 OBE
Trustee5
Dr C Wilson (Chair)
Mr G Murrell (w￿e-ChaIr1
Mr S J Nicklin
Mrs L Iloliday
MrD Lei8h-Hunt
Dr D Stableforth
Mr J Evi50n
Or S K Seeley lapfv)inied 8 April 20241
M5 S J Heale5 (appointed 8 October 2024)
ExUfkk)
Chairman of WarwKk Distrtt CourKII
His Worship the Mayor of Royal Leamiwn Spa
Senior Mana8ement Team
Mrs M 8awden (Chbef Exec￿l¥e & Nomin*ed individuall
Mrs E Jackson (Deputy Chief Executi¥e)
Mr A Albu (Registered Manager. Lillington House and Helen Ley House
Mi55 N Fyfe Iclinical Services Manager)
Ms K Gates Iclinlcal Quality Improvement Mana8erl
Company Secretary
Mfs M 8awdÈn
Care Standards Committee
Mrs L Holiday (Chaif l April - 8 0(tober 20241
Or S K Seeley (Chair 8 October 2024 onwards)
Or C Wilson
Mr G Murrell
Mr S J Nicklln
Mr D LeEh.Hunt Ire5igned l July 20241
Dr O Stableforth
Mr J Evison
Mr$ 5 J Heales
Flnance. Assets & Rlsk Comrnttlee
{includlni Pfofiling & fvndraisirql
Mr G Murrell (Chai
Dr C Wilson
Mr 5 J Nicklin
Mrs L Hollday
Mr O Lei8h-Hunt
Dr D Stableforth
Mr J Evison
Dr S K Seeley
Ms S J Heabes
Remuneration Committee
Mr D Lei8h-Hunt (Chair l April - l July 20241
Mr J Evison (Chair l July 2024 onwards)
Or C Wilson
Mrs L Holiday (resigned l July 2024)
Dr S K Seeley (appointed l July 20241
Mr S Nicklin
Mr G Murrell

CASTEI FROMA NEURO CARE LIMITED
la c¥*npany Umlted ty ow•rteel
TRLisfEES' ANf4VAL REPORT (cortirn*d)
FOR THE YEAR ENDED 31 MARCH 21ll5
OBJEcnvES AND AcrwnES
Misskm Stateft*nt
Iky. resplre and Iw4erni resldefttlol core *4th 2+how rninlft4 cort fvr those vAth neurowtal ¢ondklDns
We run outstandlng care and rehabilltatlon centres provkllng day. respSte and knng-lerm serylces for people disabled
by neurological Conditions.
To wovide the highest stsndard of nursin8 and care for Individuals with neurological condilions who have
complex needs:
To bring tOReiher eJ(perts from every therapeutic field to help our residents live as full a lrfe as possible,.
To integrate family. friends and the l¢)cal Community Into the lives of our residents and provide a supportive
environment for their carers,.
To excel in palliatrve and end of lrfe care to help our residents live their lart days as they would wish. Iree
Irom paln and with as much dignity as possible-
To extend our care Iwnd our centres. into the local community and onto a res￿rIal and national level,.
To operate wrthin a finatKially and environmentslly sustsinable Iramework.
Princip¥l •¢<Nibe5
The principal artivty of Castel Froma Neuro Care Limited is the Provision of care and accommodation for severelv
physical￿ dlsabled people. To achwe th￿ obiecljve the d￿rity operales Iwo registered care ¢ertres b45ed at the followin
addresses=.
Lillington House
93 Lillin8ton Road
Leamirsgron Spa
Warwickshlre
CV32 6LL
The Helen Ley Care Centre
8eficoie Road
BIKkdown
Leamin%ton Spa
Warwickshire
CV32 6QP
The centres provide 24-hour nursing care. in addition to physiotherapy. occupational therapy. hydrotherapy, speech
and lan8Ua8e therapy. awomatherapy and reflexolo8V.
The principal activty of Royal Midland CountiEs Horne for the Disabled 15 tD 5UPPOrt Ca5tel Frorna Neuro CarE Limited. The
sale of approx*natety 1.5 acres ol land in 2(Xll alowed Royal Midland Counties Home for the th"sabled io invest a large
sum of money in property. The monihly incorne has been allocaied to projecis in Casiel Froma Neuro Care Limlted for
physically disabled people. Al of the projects have directty benefited the residents.
Volunteers
In addition to approximatety 217 pahl employees, thecharityalso benefrts from in excess of L(KXI hour5 of donated time
each ¥ear. Th15 fi8ufe includes Ilme spenl al the care centres committee members. drivers and letter writers.
who all participate in fundraising e%*ntS. Vlsit residents, and Kcornpany them on excursions outside the care ￿￿tre.

CASTEI FROMA NEURO CARE LIMITED
la c¥*npany Umlted ty ow•rteel
TRLisfEES' ANf4VAL REPORT (cortirn*d)
FOR THE YEAR ENDED 31 MARCH 21ll5
STriICTURE, 60VERNANCE AND M*I4AGEMEN7
Cistel Froma Neuro Care Llrnkted Is a charrtable company limited by guarantee. Incorporated on 27 May 2003 and
re8iStered as a charrty on l Decernber 2003. The company was established under a Memorandurn of Association. as
amended ty special fesolutions of 7 Novembef 2LK13 and 25 November 2010, which eslablished the objects and powers
of the company and i5 governed under it5 Articles of Association.
Royal Midland CC￿ntieS Home for the Disabled 15 an unirKorporated a55ociation Set up under a Trust Oeed dated 2PJuTre
1884. as amended on 1st April 2011.
Oryanlsatlon and struaure
The overall management of the thar￿ is carrnd out ￿ ttre Chief E¥ecutlve who b dlrectty reSpor￿ble to the trustees. All
nursing and care staff report to the Rewstered Mana8ers and all rKin-medical staff report to their relevanl line mana8er.
The members ol the SenM)r Managemeni Team comprise the Deputy Chief Executive. Regisiered Mana£ers. Clinical
Quality Improvement Manager and Clinical Servi¢es Martager. all of whom report to the Chief Executive.
GOVern•n￿ and internal wrtrol
The '8oard of Trustees. Comwises the directors of the compary. A list of tl*>se served In these capacitles durin8 the
period is Set out on page 3. Member5 Ot the company guarantee to tontribute an amount not exceeding £10 to the a55ets
¢1 rhe ttjmpany in the event of windln8 UP.
A panel comyisin8 existin8 commrttee members selects members of the three committees.. the Care Standards
Committee,. the Finances, Assets and Risks Committee: and the ReMUnerat￿n Committee. The trustees meet quartertr4.
New trustee5 are eberted by the'8oard of TQ￿ees'. N￿¥ trustees are indurted durin8 their first trustee< fftttir*, Tru5Lee5
are encouraged to appropriate external trainin8 evenis where these will facilitate the undertèkin8 of their role.
Pay pollcy for senlor st￿1
The pay of the senior staff is reviewed by the Remuneratlon Committee lat least annually) and normally Increased in Ilne
with average earnings. In view of the nature of the charity. the trustees be￿hMark against pay bevels in other regional
charities of a similar size. ff recruitment has proven drfficult in the rKent pèst a market addition may also be pald.
Pl•nsfor the fviure
In January 2025 the extenst4n ai Helen Ley becanx opeiatlonal and has wovlded an addrtlonal eleht en-sulte bedr¢)oms at
that site. The extension forms pan of a viider re￿W by trustees of the chartvs premises in the context of the need for
the charity to al*n its care servkes wrth Cha￿e$ in n￿deffl heahkare ser¥¢es. includin8 an Increased focus on
rehabilitation.

TEL FROMA NEiIRO CARE LIMITED
(a c(¥np•ny Ilmlted by Dwarteel
TRUSWEES, AIIIIVAL REPORT IcontwK*d)
FOR THE YEAR ENDED 31 m￿tCH 2025
STIIATEGK REp£￿T
2024-25 was another extremely challen8in8 year as the charlty, Ilke many In the sectof. was dealin8 Wlth signiflcant
intlationory pressures in the economy, including an increase in employers, National Insurance. that were in part
exacerbated by a volaiile wlitkal envlronment around the world.
Wecontinue to strive to provide a high standafd of care for all of our residentsat both sites. Tothis end, we have where
possible, maintained Ihe number ol hours each week In respect of physlotherapy, occupational Ihefapy, psycholo8v.
dietician and speech and longuage therapy. The latest CQC inspection reports Still assess both sites as'Good'. The latest
lrts&>ettloN at Helen Ley House was carried out in-person In January 2025 whilst the most ie¢ent inspection for
Lillington House was a desktop review.
Fin4NKial revievj
Details of the financial position of the charity are set out in the attached f I￿ntIal statements. Income tor the year
totalled £9.379.311 and expendlture totalled £9,969.926. Net eX￿ndIt￿re and the net movement in funds for the
year totalled £590.615. Unre5trKted reserves at the yeaT-end amounted to £9.641,025 and these comprised general
reserves of £2.821,415 and designated reserves of £6.819.610. Restricted reserves comprise the restrkted reserves
of Castel Froma Neuro Care Llmrted totallln8 £18.860.
Durln8 ihe year. Ihe trusiees tonsulted the Charity Commisslon and took approprlate legal advke to explore the
possi￿.1[tY of the endowment fund. which at f4,250,(W. represented the majority of the value of the site at Lillington
House, being released from its restrlcth?n and transferred into unrestl￿ted luThJs. Thls corresponds wlth the char1t￿5
longer-term airn to widen the extent of it5 5eT¥i(es as detailed on page 8.
Le8al advice was clear that the charity could proceed and accordin8ly. a tiansfer has been made to effecl this. The
endowment fund now has a value of £Nil and the general fund was increased by £2,388.(W. being the anticipated
realisable value of the sale of ihe relevant parts of the slte, wlth the balance of £ 1.862,000 transfefred Snto deslgnated
funds.
knvestrnent polky
The charit￿5 investments are held in accordance with the trustee5' powers. The irustees hèd previously considered
the most appropriate policy for investin8 the funds and found that a mixture of property Investment and investment
in a portFolio of equities had, at that time, met their requirement5 to generate both income and capital growth. Since
the disposal of its remainSn8 investments in 2024. there has been more focus on the charlty ensurin8 that cash is
available when needed.
Rlsk fevlew
The trustees have put In plxe a formal risk ma￿6eMent prrxess to assess business rlsks and Implemenl risk management
strategies. This involves identifying the types of risks the charity faces, prioritisin8 them in terms of ￿tentIal impact and
Ilkellhood of occurrence. and Identlfying means of mlllgatlng ihe rlsks. As part of ihls process ihe trustees continually
review the adequary of the char￿5 current internal contro15. The tru5tee5 arE pleased to reFort that the charity'5 internal
financial controls. in partitular. conform to 8uiddiros issued by the Charity Commission.
The trustees have corrflucted thelf own review of the rn4￿r rls*s io whkh the charbty b exposed. and systems have been
implemented to mit4gate those risks. The signrficant external risks to the charity are noted within the key risks identified
below and include the flnan¢lal risk of the ¢harlty not meetin8 rts budget. Internal risks are minlmlsed by the
implementaiion of internal contiol procedures for authorisation of transact￿n5 and projects and through sraff
development. These prtxedures are reviewed periodi￿lIv to ensure thry still meet the needs of the charrty.
The key risks as identified by the twstees In¢￿de.
Residents. lees as awarded by Commissionery not keepn8 pace with inllation and the ensuin8 difficulty in
achwing a balanced bud8et. 8b¥en the requlreffent to meel and malntaln the charitrfs repulation and
commitment to care standards..
Delayed settlenwnts from debtors. Wln8 to an adverse Imp¢t on cash fvw and a resultant deLay In settlemènts
to suppliers.

TEL FROMA NEiIRO CARE LIMITED
(a c(¥np•ny Ilmlted by Dwarteel
TRUSWEES, AIIIIVAL REPORT IcontwK*d)
FOR THE YEAR ENDED 31 m￿tCH 2025
STIIATEGK REp£￿T
The trustees have examined the chaftt(s wuirements for reserves in the light of the main rtsks to the organisation and
have esiabllshed a [x)I￿V whèreby sufficient unrestricted re￿r¥eS afe retalned in order to meet unforeseen increased
working capital requirement5 at a level equal to at least Six months, operating expenditure. In April 2021. the trustees
further clarified the reserves poliry with an addilional aim to hold a level of reserves in liquld assets such as cash
deposits or investment lunds of at least thret months. operating expendlturé. The polKy wès reviewed again In 2025
and is still considered to be appropriate.
The Sirategy of the trustees ts guided by the following principles:
To build re5er¥e5 through planned operating surplu5e5,'
To review the poliry reguLidy in the light of financial performance and any changes in risk as5e55ment,'
To apply thls pollcy in coniunctlon wrth the Investment pollcy. to enable a proportkjn of the reserve to be
invested, and
To limit the abiltty of the charity to draw from rts reserves by only authorising the Chief Executrve or Chair of
the Trustees to èmect such a drawdown. with an obligat￿￿ io repoft and such withdrawal to the 8oard.
Followlng the lègal ath4ke taken regardl￿ the statu5 of thè endowment fund and the transfer effected from that
fvnd. the level of unrestritted reseryes at the year*nd was £9.641.025. of which there was a des18nation of
£6,819.610. This designated fund represents the maprity ol the net book value of the lunrtional fixed assets ol the
charify and is thefefowe nor deemed to be available to the ch8rily for activilies other than io which these assets are
currently committed. The level of reserves available to the chartty for unlore5een workin8 Capital requirement5 Was
therefore É2,821.415. which. ar Just over three months, operating expendiiure. Is short of ihe six months tartet.
based upon current le¥els of activity and bvd8et5 for the forthcoming year5. Liquid asset5 are a150 bekjw target. However,
as part of the trustee5' wider strategic review of the char￿5 premises. the decision was taken to sell part of the site at
Llllinoon House. and wilh flfm offers In pl&e. this f• ex&￿ed to 8eneTaie cash of o¥tr £2.3mllllon in 2026 (reflected In
current assets in the balance 5heetl. hence the charl￿$ liquidity position is considered to have con5iderabty eased in the
short to medlum term. The trustees therefore conslder that the current level of reserves is adequaie for the charlty to
meet its Obl￿tiVes.
Valuatlon ol prwrti•s
As part ot rhe wider revlew of the chartys premlses and the legal athke taken on the enthwmert fund, the charity
obtained valuations of the Lillington House 5rte towards the end of the tinanciol year. The wlK¥le Site wa5 valued in the
region of £4.51N).IXKJ and thus not deeff*d to be impaired when compared io Its prew¢)us carryln8 value. Separale
valuat￿n5 were obtained fof rhe elements of the sr(e intended for markering and resabe and, with other modificarion costs
factored into the offer5 made. £2.388.CO) has been transferred from fixed a55et5 to current a55ets.
As there has been $18niflunt further Investment In Helen Ley House. since its lall valuation. a fresh valuatlon wlll be
considered in 2026 to ensure its carryini value remains appropriate. The trustees are satisfied that at the year end
the slte was IKJt impaired and that its current carryin8 value is appropriate.
No adlustments were therefore mède to the carryln8 values of the propertles for the year er4Jed 31 Mèrch 202S.
Fundra14r
Whilst charity (h)es incur some expenditure in respect ol lundrnising activiries, including prolessM)nal fees for a third.
party a8ent in respect of corporate charty donations, these are considered to be on a small ￿ale and do not form part of
the charitvs principal artviities. The charity neither part￿1PateS in publicty marketed fundraisi￿ events nor in the actv4e
soliciting of donations from members of the general public. Accordin8ty, the charity is not ￿lIStered with the Fundraisin8
Règulator. although the trustees will keep the situatlon undér review.
The trtsstees ¥￿tsId like to acknowledge their sincere gratitude for the donat*or6 in the ￿ar trom: The Edward Cadbury
Trust. W A Cadbury Trust and Tr* RowlarndsTwst. The maiorty 0fttr￿ ch)nations were to supplyfumiture and equipment
for the Helen Ley eXtens￿Th.

TEL FROMA NEiIRO CARE LIMITED
(a c(¥np•ny Ilmlted by Dwarteel
TRUSWEES, AIIIIVAL REPORT IcontwK*d)
FOR THE YEAR ENDED 31 m￿tCH 2025
STATEMENT OF PUBLIC BENEFTW
Thè trustees are ￿￿ndful of the need to demonstrate wbllc beneflt In the opwat6on of both Royal m￿land Countlès Home
for the Disabled IRMCHDI and Castel Froma Neuro Care Limite(l. For many years the dwrity had Operated at a tradin81055
and had been wholly dependent upon RMCHD to provide substantsal donathjns in order to keep the charity running. The
trustees afe now pursuing a slrale8y of maintsiniwd iealistic fee levels whilst also ensuiin8 that costs are aclNety mana8ed.
which has started to produce financial stability forthe charity.
The tn15tees have thly considered the Charity commis5K￿,5 published 8uidawKe on public berrfrt requirements under the
Charitles Act 2011.
As such. Ihe trusiees carni cMJi those objects and actfr¥rtles by contfaCtIN8 with, amort8Si Others. NHS En8land and varlous
Inte8rated Care Board5 to provide'.-
Rehabilitation ot •ndi¥idualsfolbwing catsstroph¢ TrAain traumas. and
Continuin8 specialist and complex cère for indwiduals wrth on801￿ brain related trI￿rn3$and physical disabikiies.
As a result ol this. the charity is deemed to demonstrale a public benefrt in assi5tin8 the NHS and other public l)odies by
offerin8 a n￿re tallored solution to these Ir￿￿Idual5 whose com ￿e¥ and often ￿ng.teTrn care needs would othenvise
place a 5i8nificant burden on publicty funded resou￿e5 and facilitie5.
Furtherniore, in common wrth other charities in the care sector, the fees charged to res"NYents are based on a structure of
cost reco¥Èry that e￿endS onty to dlreet care costs and artcilary oveth*ads. but byhkh exdudes a d￿rge for room rerttsl.
As yxh the charity is considered io offer a demonstrable publK benefit to residents. their familie5 arKI wider society in
providing thi5 servlce within the context of its overall care obligations.
The tharity ks optn to all may benefit from tht high￿ Inter&l¥e servkes offered at Castel Frcmna Neuro Care Limited.
We know we could do rMre and that is why we are 5eekin8 to provide more appropriate facilrtie5 and surroundin8S to
support the more complex needs we need TO meet. A broader range of servkes is contemplated which woukl offer further
support to t￿$¢ needin8 the spedalised servke we #￿er. This appro•th is enllrely drlven by the charltls oblectlve of
relie¥in8 person5 With physical disabilities by the provision of care.

TEL FROMA NEiIRO CARE LIMITED
(a c(¥np•ny Ilmlted by Dwarteel
TRusfEES' ANNUAL REPORT 1contlrn￿dj
FOR THE YEAR ENDED 31 MARCH 2025
Trust￿ resPfy￿*IIIItIes In relatlon iothe 11n•￿Ill statern
The charity trustees (who are also dirertors of Casiel Froma Neuwo Care Lwnite(I for the wrposes ol company law} are
rtsponsiblt for yeparing the Trustees, Annual Rtport lirKluding the Strateglc Report) and the financlal statements In
accordance with applkable law ènd Unlted Kin8dom kcountin8 Standards (Unlted Kin8dom Generally Accèpted
Accounting Practice).
Company law rewires the trustees to prepa￿ financial stateff*nts for each tinanc￿l year. which ￿Ve a true and fair view
of the state of affalrs of the tharitible tornyny and of the Intoming fesourtes and application of resourtes. in¢ludin8 the
IT￿orne and expenthture, of charrtable company for that perKJd. In preparin8 these financial ststemerrts. the trustees
are requlred to..
select suitable accounting polic*s and then apply them consistentlv,.
observe the Methods and princi￿eS In the Charrtie5 SORP 2019 IFRS 1021:
make judgements and estimates that are ￿aSOnable and prudent.
state whether applicable UK aceountlng standards have been followed. sublert to any material
departures disclosed and exploined in the tinancial ￿ateMents..
prepare the financial statements on the going concern basis unless it Is Inapproprlate to presume that
the charTty will continue in opefation.
The trustees are resF¥)nsible for keeping proper accounting records that di5d95e with reasonable accuraci at any time the
rinancial position of the char[tab￿ company and enable them to ensure thal the flnanclal statements comply wlth the
Companie5 Art 20￿. They ère a150 responsible 101 5afe8uarding the a55et5 of the charrtable company and hence IOT takin8
reasonable steps lor the Pfevention and detecr#?n of Iraud and other irregularities.
Statement as to dbdowre to our
In so lar as ihe irnstees are aware ai the t1￿ ol appfovlr* our trustees, annual report.
tlxbre is rn ￿levant audii inforMat￿n (rf which charitable compa￿$ auditr* is unaware: aryj
the trustees have taken all steps rhat they ouehi to have taken to make themselves aware of any relevant audit
Informatlon and to e￿¥bliSh that the auditor is aware of that information.
HB&O Ltd ha¥e e¥weMed their will1￿ne$S to contlntse in the capacity of the comparfs 4wthtcvs.
In approving the Trnstees" Annual Report we also approve the Strategic Report included therein. in our capacity as
company directors.
Approved by the m15tees on 23 Oecemiv 2025 and ygned on their ￿haIr lyr.
Dr C Wilson
Chair of Trusrees

CASTEL FROMA NEURO CARE LIMITED
la comp•ty Ilrnlted by 8u¥*rtee
INDEPEPIDEIIT Avo￿OR,5 REPORT TO THE MEMBERS OF CASTEI FROMA NEURO CARE UMITEO
FOR THE YEAR ENOED 31 MARCH 2025
Oplnlon
We have audited the financial statements of Castel Froma Neuro Gire Limited Ithe 'charitable compan￿) for the year
ended 31 March 2025 whlch Comprlse the Statement of Flnancial Actrélties. the Balance Sheet. the Statement of Cash
Flows and notes to the f inancial statements. includin8 a summary of si8nificant accountin8 policies. The linancial
T@￿rtIng framework ihat has been applied in their preparation is applicable law and United Kingdom Accounting
Standards, includin8 Financial Reporting Standard 102 Yhe Finan¢i41 Reporting Standard •ppli¢able In the UK and
Republic ol Ireland" Iunited Kingdom Genernlty Accepted Accounting Prarticel.
ID our opinion the financial Srateffw￿.
give a true and fair View of the state of the charitable company's affairs as at 31 March 2025. and of its incomin£
resources and application of resources. includine rts Incorne and expenditure. for the year then ended..
have been proper￿ prepared in accordance with Unrted Kingdom General￿ Accepted Accounting Prnctice,. and
have been prepared in aCcOrda￿e wilh the requirements of the C(wTrpanies Act 2￿.
Basisfor op•nh)n
We conducted our audit in accordance with International Standards on Auditin8 IUKI IISAs IUK)) and applicable law.
Our r@s￿)nSibl11[IeS undér those standards are further described in rhe Auditorfs respOnsi￿.11t1￿s for the audit of the
financial 5tatemen15 sertion of our report. We are independent of the charitable company in accordance with the
ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC'5 Ethical
Standard. and we have fulfilled our other eihical responsibilities in accordance with these requirements. We belleve
that the audit evidence we have obtained 15 suff icient and appropriate to provide a basis for our opinion.
(crfK￿￿0N$ relat[￿ to 8olng cr*Kern
In audrtin8 the financial statements. we have concluded that the trustees, use of the 8oln8 concern basi5 of accountin8 in
the weparation of the linanclèl statements Is appropriate.
Based on the work we ha¥e performed. we have not bdentIf￿d materlal uncertaintles relat1￿ to events or condltlons that.
i￿liVidualty or collectively, may cast $18nrficant doubt on the charitable companW5 abilityto continue as a going concern
for a pèrbod of at ￿ast twefvt months from when thè financ￿1 statements arÈ aUthor￿ed tssuè.
Our responslbilltaes and t￿¢ responslbllilies ol the truslees wlth fespecl to g0Sng CO￿ern are descrlbed Sn the relevant
sertion5 of thi5 report.
io

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
INDEPENDENT AUDffOR'S REPORT TO THE MEMBER5 OF CASTEL FROWI NEURO CARE UMITED Icontirn*dl
FOR THE YEAR ENDED 31 MARCH 21)25
The other Informatlon comprlses the Informailon Included In ihe Trustees. Annual Report, other ihan ihe flnanclal
5tèternent5 and our auditorf5 report thereon. The tru5tee5 are responsible for thp other information containpd within
the Trustees. Annual Report. Our opinM)n on the financial statements does mt cover the other intormation and, eycept to
the exlent oiherwi5e explicltly stated in our report. we do not express any form of assurance concluslon thereon. Our
responsibility is to Tead the other information and, in doing so, consider whether the other information is materially
IKorfjistent wrth financlal statements or Qui kTh)w*d8e Obta1￿ In the course of audlt or othep*415e appears lo
be materially misstated. If we identtfy Such rnaterial inconsistencie5 Qr apparent material misstatemenls. we are
required to determine whether this gives rise to a material misstatement in the financial statements themsefves. If.
based on the work we have performed. we condude that there ts a materlal misstatement of thts other informatK*n. we
are required to report that fact.
We have nothlng to report In thls re8ard.
Opiniorts on other mattets presc¥AJed ty the comp￿•t5 Act 21%J6
In our oplnlon. based on the Wofk undertaken In the course of tPe audft:
information 8i¥en in the Trustee5' Annual Rewrt li￿01￿)rating the 5trategK report afKI the directors, reportl ft)r
the financial year for whi¢h the financial statements are prepared is consistent with the financial statements,. and
the straie8ic report and direttors. report have been prepared in Kcordance with applKable legal reqUI￿rnent
M•tt•r5 on which w• •r• r•quir•d to r•port by
In the l¥ht of our knowledge and understanding of t1￿ charIta￿e cory•ny and irs environment obtsined in the course of
the audit. we have not idenilfied materlal mlsstatements In the slrategk report and the dlre¢tors' report.
We have nothing to report In respect of the follow•n8 matters In relatlon to which the Companies Act 2CM)6 requlres
U5 to report to you rf, in our otynion-
adequate accountlng records have nol been kept. or returns adequale for our audlt have not been re¢elved from
branches rbot Visited by us.. or
the finarKlal ststements are not In agreement wrth the accountlre ￿ordS and ￿turnS,. or
certain disclosures of d1￿ctors, remunerat￿ specrfied not made: or
we have not rectlved all the inforrn4b.on and explanaiions requlre for our •udll
R•sP￿￿111tA￿ ul trust•e5
A5 explained more lully in the Trustees. Responsibilities statement Set out on page 9, the tru5tee5 Iwho are a150 the
directors of the charitable company for the purposes of company law) are fesponsible for the pieparation of the
financial statements and for bein8 satisfied that thvi 8ive a true and fair view. and for such interr)al control as the
trustees deiermlne is necessary io enable the We￿ration of financlal statements that are free from material
misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to
continue as a going concern. distlosing. as applicable, matters related to going concern and using the going concern
basis of accountin8 unless the trustees either intend to liquidate the charttable cornpany or to cease operations, or
have no realistic alternative to do so.
li

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
INDEPENDENT AUDffOR'S REPORT TO THE MEMBER5 OF CASTEL FROWI NEURO CARE UMITED Icontirn*dl
FOR THE YEAR ENDED 31 MARCH 21)25
Audltrfs r•sPwsSblll￿ tor th• wdlt of the Ilnandal sM•rnents
Our objertives are to obtain ￿0$oftable a55urarKe abovt whether the f inancial statements as a whole are free from
material missraiement. whether due to fraud or error. and ro issue an auditorfs report rhai includes our opinion.
Reasonable assurance 15 a high level of a55urance, bul it 15 not a guarantee that an audil conducted in accordance with
I￿S IUKI will always detect a material misstatement when it exists. Misstatements can arise f rom traud or error and
are consldered materlal If, Indivkjually or In the •ggre8ate. they could reasonabty be expected io Influence rhe
econornic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud. are instances of non<ompliance with laws and fegulations. We design pr¢xedures in
Ilne wlth our responslbllitles. outllned above, to detect material misstalements in respect of Irregularilies. Includlne
fraud. The extent to which our byocedures are capèble ol detectin8 lrregularrt￿$. includin8 fraud, is detailed below..
The audit process includes an assessment of the entity's risk enwronment. through el￿￿lry of and discussion with
management and those chaiged with governance. includlng an assessmenl of ary key la￿ and regulatknns wlth whlch the
charrtable company must comply in the ordinary course of its operations.
Additionalty, the overall risks of irregular transactions occurrin8 are assessed fol￿wing our observations and
confirmaiion of the design and implemenialion of m4na8emenl's controls. Whilst we are mindful of these risks. our
audit focus is geared towards the risk of material mi55tatement in the financial statements as a whole.
A5 Such. our procedures cannot Kuarantee that all transartions have been fully compliant with all relevant laws and
regulations. including those regulaiions relating to fraud. as our procedures afe not designed to detect all instances
ol norFiompliance. By definition. the risk of our detertion of non-romplianie is greater wheie iomplionce wtth a law
or regukition is rerno¥ed from the events and tranSaCr￿n5 reflerted in financial ststements. The risk is also greater
re8ardlng Irregularities due to fraud rather than ffror. as fraud Involves Intenllon•l concealment, lor8ery. colluslon.
omi55ion or misrepresentation.
A further description of our responsibilrties is available on the Financial Reporting Council's website at=
udi
This description forms part of our auditorfs report.
Use ol our report
This rewn is made solely to the Charitab￿ compan￿5 membefs, as a b(Mty. in accordance with Chapter 3 of Part 16
of the Companles Act 2006. Our audit work has been undertaken $0 thai we might Stale to the charitable company's
meml)er5 those matters we are required to State to thern in an auditor's report and for no other purpose, To the
fullest extent permitted by law. wt do not accept or assume responsiblllty to anyone other than the charliable
mpany and the charitable company's mernbers a5 a body, for our audit work. for this report, or for the opinions we
have formed.
Mark A5hfield BA FCA15enior Statutory Auditor)
For and on behalf of HB&O Ltd
Chartered Accountants and stat￿Ory Auditor
Highdown House
IIHighdown Road
Leamlngton Spa
Warwickshire
CV31 IXT
23 December 2025

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
STATEMEKf OF FINANCIAL ACTivmES linthdirya irKoffle and experxliture ￿￿ount1
FOR THE YEAR ENDED 31 MARCH 2025
R*strfctsd
Endowrnent
Funds
Totsl
2025
Totsl
2024
Funds
Incorne and endry*ments frryn:
DonatN)ns and legacies
Charitable activities
Operation of care centres:
14.039
79.850
93,889
371,945
Residentlal lees
9.222.836
9.222.836
8.424.443
Invesimen
31,618
31.618
158,066
Other
30.968
20,378
Total Incorne and end￿*M¢*
9,299,461
79,850
9,379,311
8.974,832
Expendlture on:
Raising funds
18.783
18,783
96,$11
Charirable artr¥rtses: Operation ol (are
centre5
9.931.910
19.233
9.951.143
9.122,476
Total expendlrure
9,950,693
19,233
9,969,926
9,218,987
Plet lexpendllurev Inco
1651.2321
60.617
159J.615)
244,1551
Transfers between funds
17
4.123.1)Xl
14.323.IXA)I
Other r•(ognls•d la1￿/1105%•5).
Other 8ainsl Ilossesl
42.746
Il•t m(wefflert kn lunds
3.671.768
{4.262.3831
1590.615)
1286.9011
Re(oncili*ion d lund5
Total fund balances t*OU8hi forward at i
April 2024
17
5.969.257
4.281,243
10.250.5
10.537,401
Total fund balances carl￿ éonvard at 31
March 2025
17
9,641.025
18,860
9.659.885
10,250.5(K)
All income ond expenditu￿ derive from continuini activities.
The staten*nt of fIna￿la1 èctivltles Includes all 8alns and losses ￿¢08n1$ed I￿￿nE ihe wr.

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
BALANCE SHE￿ AS AT 31 MARCH 2025
2024
Axed assets
Tangible amets
6829.167
8.896,076
6.829.167
8,896,076
Current assets
Srock and assets held for resale
Debtors
Cash at bank and in hand
li
2,435.068
459.187
659,432
39,195
709.269
1.426,642
3,5S3.687
2,175.106
edltors: amountsf•Thw wlthln ¢)ne year
1722.9691
1820.682)
2,830.718
1,354,424
Tot•1 assets less current M•blttles •rnl net •sieis
9,659,885
10.250.5CK)
Unrestrfcted fvnds
General lund5
GeneTal
17
2821.415
1,339,473
Tot•1 General
2.821.415
1.339.473
17
6319.610
4,629,784
9.641.025
5.%9.2S7
Rostrfcted funds
17
18.8EA)
31.243
End￿alment fund
(h￿￿ by Casttl Froma He￿0 (art Ltd asa trust*o
of RMOIOI
17
4.250.LMJJ
Totalfunds
9.659,885
10.250.5CQ
These accounts were approved by the Board of Trustees ¢Jn 23 December 2025 and 5[￿d on its beholf
OR C WILSON
Chair
14

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
STATEMEKf OF CA5HFU>WS FOR THE YEAR EP40ED 31 MARCH 2025
2025
2024
Cash {u5ed Inv w￿11￿ed lry Operati￿ actmi
(277,0311
60.599
Cash fltrws from Invésolrf artl¥ftles
Payments to acquire tangible fi.xed assets
Receipts from disW5al of fixed a$5et
Investments
Recelpts from dlsbx>sal ol fL*ed assets
Interest received
Rents received
Cash (used inl/ pro¥kled by kwestiry artr¢il*s
I540,41￿)
1983,8881
2,864,838
I8.￿3
12,228
19,390
{490.1791
7,354
150.712
2,039,016
Cash fl¢Msfrom fln￿dty aal¥4tles
New loans
Repayment of k)an5
Interest paid
Cash used In financ1￿ a¢thrftles
S07,500
11,462,8071
147.74S}
11.fy)3.052)
IDecreasell in(vease in o5h and cash
equivalents
Cash and cash
ewI¥¥￿nts at l Aprll
1767.2101
l.(Y36.563
1,426,642
330,079
Cash and cash •qufvalents at 31 Marth
659,432
1,426,642
Cash and cash equl¥ale•tsconslsts c*.
Cash and cash equivaleDts at 31 March
659.432
1,426,642
Anatysis of thary•5 in n•¢ fvnds
Atiw
At31 Marth
2025
Cash and cash equlvalents
1.426.642 1767.2101
659,432
Total net lunds
1.426,642 1767.2101
659.432

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
r40TES TO THE STATEME1￿ OF CASHFU)WS FOR THE YEAR ENDED 31 MARCH 2025
L ReconcHlatlon ol r*t ftwèment In lunds to net cash tlow Irom operatln8 acll¥hles
2024
Net movement in I￿￿ts
1590.6151
I286.￿1}
Renls receb4ed
Interest ￿ceiVable
Inte￿$t payable
Depreciation of tangible fixed assets
Profit on disposal ol tangible fixed assets
(Gainsll losses on In￿stMentS and investment syoperty
Ilncreaselldecrease in stock
Cjecreasellincreasel In debtors
IDecrea5el/ increase in credrtor5
119,390)
112.2281
1150,7121
17,3S41
47.745
258.541
212.706
112,CKX))
42,746
55.102
1155.9731
257.405
17,8731
250.OB2
197.7131
cash {used inll provthjed by operating aaivit*s
1277.0311
60,599
16

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
P40TES TO THE FIIW4CIAL sfATEMEKt5
FOR ThE YEAR ENDED 31 MARCH 1025
Prln¢lpal polk*s
The pri￿1paI accountiry policies adopted. iud8ements and key sources of estimatM)n uncertèinty in the preparation of the
rinancial slalements are set out below as f01h￿s. These policies have been consistently applied unles5 olherwSse staled.
al 8asls of wep¥•t
The financial statements have been prepared in accordance wrth Ac¢ountin8 and Reportin8 by Charlties= Slatement ol
Recommended Practiie applicable to charities preparing their account5 in accordance with the Financial RekK)rting
Standard Jpplicabie in ihe UK and ftepubl￿ ol IreLind ssued in October 2019, the Financlal Reportine Siandard appllcabl¢
in the UK and RepublK of Ireland IFRS 1021 Companies Acl 2(*)6 and UK General￿ Accepted Accounting Prartice.
Castel Froma Neufo ca￿ Limlted rne￿5 the definition of a wblic benefit entity under FRS 102. Assets and Ilabilitles are
I￿llIallY re¢o8nlsed at historral cosi or transaction value unless otherwise stated in Ihe relevant è¢¢ountin8 policy r*gtelsl.
The financial sLitements are presented in sterlin& which is the funct￿lIa1 Curre￿ of the rharrtable company and rounded
to thè nèartst £.
b) Pr•paratityb ol1￿ a￿)Unts on • i¢iry conc•rn b￿1$
The tharity reported an adverse net mvement In furwas of £5￿1,615. Ho¥vever. it should ￿ noted that thls pèrformance
was again in the context ol stubborn inflationary pressures in what has continued to be 3 volatile economic and wlttical
environment. The trusiee5 consider that the chaflty'5 f￿Vre plans. which will include a focus on rehabilitation and care of
clinically comp￿1 cases combined wth an oreoin8 review ol premtses. will result In •n over)11 redUct￿n in expendrture as
perientage of incor￿. The IoTeca5t5 lor operating (ash flows, partKular wtth the Imminent sale of part of the Lillington
House slte. together wtth the level of reserves. suggest that the charrtvs future IS secured for ai leasi 12 months folbwlng
the authorisation of these accounts. Accordingly. on this basis the trustees consider that no rnaterial uncertaintie5 exist
and that the charitable cornpany Is therefore a golng concern.
¢) IrK(xne
Income Is recognised when the charity has any entitlement to the funds, any ￿rforma￿e condltions attaC￿d to the hems
of income have been met. it Is probable the income will be receTved and the amount can be measured reliabty.
I￿oMe from government and other grants. whe￿r -capitsf grants or "revenue" grants. is re(￿nISed when t￿ chèflty
has entitlement to the funds, any pertormance conditlons attached to the grants have been met, tt is probable Ihat the
income will be re￿1ve￿ and the Jmount can be measured rella￿Y and is not deferred.
For legacies. entitlement is the eafller of the dare on whkh either.. the charrty Is aware that probate has been granted, the
estate ha5 been firsali5ed arbd notification ha5 been made by the execLrtorl51 to charity that a distribution will be Made,
or a distribution is received from the estate. Receipt of a legacy, in whole Of in pao is only considered probable when the
amount can be measured rellably and the charity has been noiified of the exe¢uiorfs inientlon io make a distribution.
Where legacies have been notified to the charity. or the charity is aware of the granting of probate. and the criteria for
IKome r¢co8nStk>n have rKJt been met. then the legacy ts trèated as a contln8ent asset and dlsclosed W material.
Ir<ome ￿¢eNed in advance of any care servKes wowded is deferred untll the criterla lor income reco8nitbn are mei Isee
note 131.
Donated facilities and donated professional sérvices are iecognised in income at their fair value when their economic
benefrt 15 probable. rft can be rneasu￿d reliabty and ttE charity has control over t￿ Ttem. Fair value is determined on the
basis of the value of the gift to the chariry. for example the arnount the charity would be willirg to pay in the open market
for such facllltbÈs and sèrvltts. A corrèspondSn8 amount Is rècognised In expendlturÈ.
17

CA5TEL FROMA NEURO CARE UMITED
(• ccfftp•ny Ilmlted by Dw•nteel
NOTES TO THE FIP4AIICIAL sfATEMEfiTS Icontwx*d)
FOR THE YEAR ENDED 31 MARCH 2025
Principal ac(￿rt￿¥ poli￿$ IconQwx*
No amount 15 included in the financial statements Icy volunteer time in line wrth the SORP. Further deLiil 15 given in the
Trustees. Annual Report.
Whère practlcable. gtfts In klnd donated for dlstrlixrtlon to the beneflclaries of the charity are Included In stock and
donations in the financial statements upon receipt. If it is impracticable to asse5S the fair value at receipt or if the costs to
undertake such a valuatlon OUtw￿h any benef￿. then the fair value is recognised as a component of donatlons when kt
is distributed and an equryalent amount reco8nised as charttèble expenditu￿.
ITrtere￿ on funds held on dekM)Sit is included when ￿elIable and the amount can be measured relia￿¥ by chèiity,. this
Is normal￿ upon notlfkatlon of the Interest pakl or payable by the bank.
I￿¢￿￿¢ from Investment property Is •¢c¢unted for M a Siral8hi41ne basls over ihe period ol the lease.
d) Fund
General funds are unrestricted funds which are available for use ai the discretion of the irustees in furtherance of the
general Objerti￿ of the charity and whKh have not been designated for ottv PUfP05es.
DeS￿nated lunds comprise unlestr￿le0 fuThgs that have been set asKle the trustees for partlcular purposes. The alm
artd use of each desi£nated fund Is set out In the rntes to the financial statements where appllcable.
Restricted funds a￿ funds whlch are io be used in accordance wrth specifk restrictions impJsed by donors or whkh have
been raised by the charity for particullir purposes. The cost of raising and administering Such funds are charged against
the spetlfit fund. The alm artd use of &3th restritted fund ks sa out In the r￿te$ to the finantlal statements.
el Exwndltyre recrynlll¢)n ar¥1 kreco¥erable VAT
AJI expendbture Is aCc￿￿ted for on an accruals basls arrtl has been classlf*d under headines thai aPAre8ate all costs related
to the cate80ry. Expendrture is recoBnised where there is a le8al or constructive obl￿atIon to make payments to a third
party, it is probable that the settlement will be required and the amount of ihe obligation can be measured reliably. It
Is cate8orlsed under the followin8 headln85=
Cosrs of raisine funds comprlse property managemeni lees and Pfoperty related interest and costs,. and staff
ènd professional fee5 4550ciated wrth rai5in8 fund5.
Éxpenditure on chariiable 3cti¥rtTres includes the costs associated wrih ihe provision of care and
ccornmodation lor 5everefy physically disabled people and other actNrties undertaken to further the
purposes of the charity and their associated support tosts.
Irrecoverable VAT Is charyed as J cost aylnst t￿ actl¥lty for ¥thth the expendllure was *￿rred.
Support costs are those functions thal assist the work of the charity but do not directly Tepreseni charitable activities
and include offKe c05t5, finance. personnel, payroll and governance costs. Where support Costs cannot be direct
attrSbuttd to particular heèdln8S. thty have been allcltèted to thè tost of raisin8 lunds and txptndlturt on tharltablt
activities. Costs are albcated to arti¥fties based on a relevant indicator for use of resources le.8. Staff allocated by
activity.. floor area of ￿lIdIn& equipment al￿ted by actb¥ityl. The bases on which suprK>rt costs have been all￿ated
are set out in note 9.

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
Pri￿1￿1 acc(￿ntin& poliw Icortirn*d>
gl Leases
Rentals payable tsnderoperatlng leases are charged to the SOFA on a strai8ht-Ilne basls over the perlod of the lease.
h) Tarylble Ilx•d ass•ts
Indi¥i(hJal filed assets Costing £1.(￿Or more are caprtalised at cosL
Tangible fixed èssets are stated at cost lor deemed costl or valuation less accumuloted deprLYiation and accumulated
Impairment losses. Cost includes tosis directly attributable to making the asset capable of operating as intended.
Depreciation is provided on all tangible r￿ed 35sets, at rate5 calculated to write off the c￿( less estimared residual value.
ol each asset on a 5V5tematic basis over its expected useful life as lollows..
Freehold land and bJildi
Motor vehicles
Flxiures. flttln8s and etyipment
0% pa.
25% p.a. reducing ba￿￿*
15%. p.a.. 20% pa. ènd 33.3% p.a. stra*ht11
Freehold land and buildings are not depreciated as the charity maintain5 the properties to a high standard and their residu31
values are regularty measwed on the basis of fair value and r￿nsta1tMenl cost as a means to assess their carrying values
In the financial statements. This infom15 an annual impairment review. which is undertaken to establtsh the recoverable
value of all properries.
Assets not meawred at falr value are revkwed for any indkatlon that the asset may be Impalred at each balance sheet
date. If such indTrcation exists. the recoverable amount of the asset, or the asset's cash generatin8 unit. is e￿Imated and
compared to the carrying amount. Where the carrying amount exceeds its reco¥erable amount. an impahrmen( loss is
recognised in the SOFA.
od( and ¥5sets hekl Ivr re5•
Stock is valued at the lower of cost and nei realisable value after making due allowance for obsolete and slowvJlKTrIiI¥
ems. Cost Includes all Costs ot purchase and other costs incurred in brlnglng stock to its present locatlon and conditlon.
Property held for resale is shown within stock at a current market value which is expected to be realised.
DebtoTh and (reditor5 rerei¥ablelp•y•* within
Debtor5 and creditors With no stated interest rate and recer¥able or payable within one year are recorded at transartK)n
prl¢e. Any losses arisin8 Irom Impalrment are fecognised In expenditure.
k) Flnartlal Insvurn•rts
Loans aThJ b)rrowirhgs are initialty recoeni5ed at the transactK>n Includi￿ transattion costs. Subsequently. they are
measured •t amortised cost using the effertrye inierest raie mdhod. Impairmeni. If an arrangemeni consiitutes
finance transaction it Is ITiea5ured at the wesent value of the future Pa￿entS di5COUDted at a market rate ol interest for
a slmblar debt Instrument.

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
Prlnc*al accountlry pollcles l<rMrtSnu•d)
Employ•• b•n•fits
When ernployees have rendered Service to the charity, short-term ernployee benefrts to which the emp￿￿5 are entitled
are reco8nlsed ai ihe undlscounled aML￿nt expected io be paid in exchange lor that seryice.
The charlty operates a defined tt*ntributb)n penskni plan for the benefrt of its èmployees. Q)ntrflxrtlons are expènsed as
they become payable.
ml Tax
The charity ts considered to pass the tests set out in ParaEraph I Schedule 6 Finance Art 2010 and therefore it meets the
definition of a charrtabbe company fof UK corporal￿n tax purp)ses. As such. it does not have liability lo corporation tax in
the course ol rts nomial chèritable artivitTres.
n) Cornp•ny status •Thd yn¢r•l infwm*im
The charity 15 a prrvate company incoryK)rnted in En8Uind arKI Wales and is limited by 8uarnntee, wtth no share capital. The
members of the company include the trustees_ In the event of the charity bein8 wound up, the liability in respect of the
iuaranlee is limited to £10 per rnember of the charity. The address of the re8lStered office and registered numbers of the
company and charity are shown in the charity information on page 2 of these financial statement5.
o) Crltlc•l •cctyJntlni estlm•tes and ￿d￿rnNts
To be able to prepare financlal Statements In accordance wlth FRS 102, the charlty must make certaSn estimates and
jud8ementS that have an impact on the w)IKies and the amount reported in the annual fina￿101 State￿nts. The estimates
and judgements are based on historKal experiences and other factors includine expectations of future events that are
believed to be reasonable at the time such estim•tes arKI jud8ements are made. The trustees do Tr)t Consider any of the
estimates or iud8ement5 applied to be s￿n[tr￿ant to the financial statement
I￿orne from donations and legac￿5 wa5 £93.88912024.- £371,945) of which £79.85012024- £27.8531 wa5 attributable lo
restrltted funds and £14.03912024: £344.0921 was attrSlxrtable to unrestrlrted funds.
Inwme from charitable actiyilies was £9,222.83612024: £8.424.4431 alj of whKh wa5 attrib￿able to unrestricted funds
and related to the w(Ni5ion of care seThices.
Ints*stm•Trt inGwn•
Rental income and incorne un(kn operatiry leases
Inrere5ta￿j dmdend irKome
19.ul
12228
150,712
7.354
31.618
IS8,￿6
All investrr*nt income in current and Pfl)r￿lS was otth.butab￿ to unre5triCted fvnds.

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
Experxlilurn on rni5iry fund5
2024
Professbnal fees foi direct ltsndraisiwd Costs
Professh?nal fees for invesrirq ￿r*it
Pffjperty management fees and ￿paIrS
18.783
23,479
15.529
9.050
47,745
Bank k)an irrte
18,783
96.511
Of the expenditure on raisin8 fund5 above. only E18,78312Q24.. £23,479) related dirertly to donation5 and le8ary
income in the finantral statements. Other expenditure 15 a5￿clated with profess￿nal and property management
fees in respect of fixed asset investments and investment property- and the cost of servicin8 the secured loans.
which were fully discharged in 2024.
All expenditure on raisinglunds in the current and pnor year was attributable to unrestritted lunds.
2￿4
Wa8e5 and ￿la
ial security costs
Pensions
6,9588
f￿7,127
133212
6.272,885
512.238
114,699
7.699.144
6,899.822
Wagesand salaries include agency and bought in staftcosts totallin8 £358.96312024.. £462,666). The trustees neither
feceived nor waNed any remuneration durin8the year12024: £NIll. No trustee was leim￿rSed expensés durin8 the
current or priof year.
The nurnbef ol staff whose eMolu￿nts lell wlthln the to1￿¥￿￿4
bands was as folkJws-_
£60.C(11 to £70,OCMJ
£70.(K)110 £80.0
£80.(K)I to £￿.c
£90,COI io £lC(I,(
£I10,￿j1 to £120,¢X
£120.IM)I to E130.C
No.
Eight 12024. Pknl employee5 earning over £60.(MJ) were accruing retirement benefits under a defined
contr11￿tIon scheme. In the year. ernpk)￿r contr11￿tiOnS of £18.12712024.' £15,0101 wefe made In respect of these
ernployee5.
21

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
Staff <osts, trustee rerwneratmjn and •xp•ns•s and the cost ol It•y
management personnel I￿ntinued)
The average monthly headcount was 217 staff12024.. 206 staff) and the average monthly number of lull.Ilrne
equivalent employees {includin8 part time stafn durin8 the year was:
1025
Mana8ement
Administration
Nursing
Ancillary ca
Therapy
Housekeepin8
SErvKe5
33
32
96
24
14
25
13
195
181
The key mana8ement of tlkb charr(y comprise tIE Trustees. the Chief Executive and nominated individual. the
Deputy Chief Executp*e and the Clinical Managers. The total employee benefrts of the key management
persomel of the charrty were as follows:
2025
2024
Key mana8emeni employee berfrts
460.637
417.741
Other ralThs and I
Oiher yins and losses Include realbsed losses of £nll12024= £1.24n In resped of ItSted investments.
Addltbonally. a rea¥sed loss of £nll 12024: É41.4991 has been retotnised on the tharrtable company's
investment property.
Net ex￿nditure
2025
2024
Net lexpenditurell income is ststed after chargiryj Icreditin8):.
Other operatin8 leases and equiprnent Iwe
OeprecIat￿ft- owned assets
Proflt on disposal of fixed assets
Income from operating kase arraryements
Auditors. remuneration
26,166
27.018
212.706
112.OCI)I
258.541
1126,9381
15,(XXI
15.OLX)
Interest payable
2025
2024
Bank loan Intewe5t
47,745

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
9 Anafysls of on tharltable acll¥lt
ofc
centrn5 Therapbps
Totsl
1025
Total
2024
Staff
Rent & raies
'8ht. heat & p￿tr
pplie5 ImedKal. catering & dean1￿)
Repairs & maintenance
Training
Subscriptions
Motor & t[￿l11n£ t￿r
InsLbrance
Bank ¢har8es & interest
Deprecialion
Ge￿ra1 expenses
5,575.391
33.4
233.398
524.145
226.486
31.631
76,705
15.794
104.734
934,973
6.510,364
38.494
268.274
602.465
260.329
36.357
88,167
18,154
120.384
5,711.042
36.930
272.486
611.775
255.9)7
23,247
71,877
11,531
122,333
16,321
258,541
118.874
7,510.864
34.876
78.320
33.843
4,726
11,462
2.360
15.650
191,435
149,824
7.163.413
21.271
21,917
1.164.402
212.706
171.741
8,327,815
Operation
ol Carg
ntres
Allocation of sUPPOrt and lo￿rna￿ costs
to artl¥ltbes
Totsl
2025
Total
2024
WaEe5 and salaries & related costs
lallocaied on
General
(pro rata to staff full time eqtsivalent)
Legal and orhef profeswnal fees
pwrt Costs
Governance costs
(all￿ated on time
'rect costs
1,(62,602
1,062.602
1,070,764
162.919
162.919
163.810
164
164
1,389,830
233.498
1.389,830
233,498
1,388,156
223,456
8,327,815
7,510,864
Totsl cost5 relatini to the operation of the care centres
Gortrnance costs compflse the followlre:"
2025
Staff costs
Le8al and professional f￿5
126,178
107.320
118,016
105.440
Eypendtfure on charitable activitTres was E9,951.143 12024= £9.122,4761 of which £19.233 12024.. £20,265)
was attributable io restricted funds and £9.93131012024- £9.102.2111 was atlribuiable to unrestricted funds.

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
FbrtUrn5
fittin85 &
Veh•des ewipmert
nd&
tA•iklir
Total
Cost orvaluadc
At l April 2024
Additions
Disposals
TTrnsfer
8.￿1.026
216,844
8.110
4.758.479
323.556
13.717,621
540.4
158.9881
12,388,IXKII
158.9881
12.388.1)Jll
At 31 March 2025
6.629,870
99,128
5,082,035
I1￿11,033
Ai i April 2024
510.420
141.416
2.855
152,385)
4,169.709
209851
4.821545
212,7
152.3851
Oi5pcwIs
At 31 March 2025
510.420
91,886
4,379.5fAI
4.981,866
At 31 March 2025
6.119.450
7.242
702.475
6.829.167
Al 31 March 2024
8.M),fA
16.7CK)
588,770
8.8W),076
Freehold land and l)uildin85 comprise the Sites at Lllhryton Road ILillin8ton House) whTch. followtnB a transfer of part of
the srte lo stock, has a remainln8 carrying Value of £1,889.535,. and at 8ericote Lane (Helen Ley Housel wllh a carrylng
value of £4.229.915.
Lilliiwon House was valued towards the end of 2024 by Wareing & Compary. with the whole slte being assessed as
ha¥in8 a realtsable vahje of E4.5W,LW. in excess of its yevious carrwn8 value. The transfer of £2.388,1K)D to current
assets in note 11 represents the arnount5 for whKh the charity has offers peTrdi￿ and subj'ect to completK)n. folbwi
Ihe Marketi￿ of these elements for resak.
Helen Ley House was last formally valued In the year to 31 March 2021 by Wareing & Company and with subsequent
extension work sI￿e then. is Set for a reassessment of its valuation in the year to 31 March 2026.
freehold land and ￿1￿ling$ had not been revalued. Ihey Ivould have been wKluded at a hi5torKal cost of £3.557.079.
Stock and assels hekl for res
2024
Domestic supph.es and consumables
FreelK)Id property held for resale
47.068
2,388,Cxl0
2.435.068
39.195
39.195
Debtors
2025
2024
Trade debtors
Prepayments and a¢cnEd I￿1rne
129.037
330,150
459. 187
281.486
427,783
709.269
24

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
13 Cveditots: am(wnts falliw the within one
2025
2024
Trade creditor5
Accruals and deferred irKome
Other taxJtion and social secur
Ot￿r credlfNS
466,844
128,454
125,fA19
2.062
722,969
540.546
140.366
134,153
5.617
820.682
Included In accruals deferred income Is fee Incon* relatln8 to later per*)ds totallin8 £60.42512024.. £32,331). Amounts of
£32,331 were released from the previous acc(yJntlng period.
14 op•r•t1￿ le•s• commltm•nEs
At 31 Math 2025 the charrty had minimum lease payn*nts under noTr<ancellable operatin8 leases as folbws..
2025
2024
Expiry dats.
Wrth*) I year
8etween l and S ￿ar5
Over 5 yea
25.136
87.428
23,926
9),720
11,1
112.564
125.806
An amount of £15,31212024'. £13.9841 15 held in tWQ secure bank accounts on teholf of residents. All accounting
records for transactions made on behalf of residents are segregated from the records of the charltable
compary.
The chailtable tompany owrates a defined contribut￿fi peThS￿n scheme In respect of ihÈ staff. The scheme and
its a$5ets are held ￿ independenl rnanagers. The pension charge represent5 contributior)s due from the
charitable company and amounted to £133.21212024= £114.6991. Included within creditors is an amount due to
stheme provlders totalllng £26.97612024.- £27.C(191.

CASTEI FROMA NEURO CARE UMITED
qa ¢(ffip•ry Ilmlted ￿ Diarantsel
NOTES TO THE FINA14CIAL STATEMEIIT5 (contwK*d)
FOR THE YEAR ENDED 31 MARCH 2025
17 Funds
At31
M•rth
2025
2024 and ab￿ k)sses
General
1.339.473
9.299.461
19.756.722)
{9.756.7221
1.939.203
2.821,415
Total General reser¥e
1.339.473
9,299,461
1.939.203
2.821.415
Fixed asset fund
Unrestrlrted funds
4.629.784
5,969,257
{193.9711
9.950.693)
2.383,797
4.323.OCKI
6,819.610
9,641.025
9.299.461
Restricted revenue funds
Nurses. social comrntttee fund
Lounge refurbishments
Soltsvare fund
Leisure and sPOrtin8 activits
Other
3.122
3.122
5.1
iio.100}
{1531
153
1,794
4.387
9.303
4.882
14.951
1.750
12.2451
112.498)
Restricted capitsl fuN
New build fund
Prolilin8 bed5
73.IX
I73.0￿)
16,292
31,243
16.7351
119.2331
9.557
18.860
79,850
173.OCQI
End¢MTment lund IRMCHDI
Total fvnds
4.2s0.l￿>
10.250.5(K)
14.250.CiX)I
9.379.311
19.%9.9261
9.659.885
The general reseNe represents the free funds of the charlty whlch are not deslgnated for partkular purFM)ses.
Des¥nated unrestrKted fund5 include reserves invested in fixed a55et5 and land and prop2rty assets.
The eThlowment fund was held by Royal Midland Counties Home for the D&)bbed comprised a permanent eThdowment
of E4,250,(K*). being the 51te of the char￿5 registered addre55 IreprE5ented within freehold land & building5 in note 101.
During the year to 31 March 2025. thè charlty t¢)ok appropriate legal a¢fvite and consuiied wlth the Charity Commlssbon.
the ups1￿1 of whth was to release IF￿$e tunds Irom the permanent endowment and enable them to be treated as
unwestrirted. Ac¢ordin8ly. a tran51er has been rnade of E4.250.(KM) from the erthwment fuTrd into unrestricted fund5.
The restrirted fund5 are those funds which have been used in Kcordance with re5trirtions imposed by donors or fvnd5
which have been raised by the charily for specific purposes=.
The nurses. social committee fund represents amounts received from the Mary Hallam estate to be spent by the
ommrttees.
The software fund represents amounts donated by Royal Midlands Counties Home for the Oi5abled and other
donor5 10 install relevant software and purchase the neie55ary SUPPOrt and te5tinu required to brin6 il bnto full
operational use.
The lelsure and SPO￿n8 artlvllbes fund represents amounts donated towards addrtbwl lelsuo and SwI￿n8 a¢tl¥ltlÈs
for the benefit ol residents.
Other rtstrkted funds Comprlse funds In relatk>n to: peop￿.$ postcode lottery: Spetthiim tralnlffj The Tent Event,. and
The English Project.
Where a transfer has been made from restricted to unre5tTicted hJrK15, this is to reflect thatthe terms of a restricted capital
donatlon have been ontt the asso¢lated f￿d assets have been ¥quired. The net t¢ok ¥aknts of the a$so¢￿ted assets
are inclu(led in the fixed a$5et desi8nated fund.
26

CASTEL FROMA NEURO CARE UMIIED
(• wrnp•ry rimit￿ trrf y•rant¢el
IK)TES TO THE F114ANCIAL STATEMEf4T5 (continued
FOR THE YEAR ENDED 31 MARCH 2025
18 An•lysL4 ol wets between fvnds
T•ft8lbl• ftx•d
Net oJrrent
Tot•1
Unr•strirt•d funds
enenl reserve
Desiinated ￿e1ve
2.821.415
2,821.415
6.819,610
6.819.610
Restricted fvnds
9.557
9,303
18.860
6,829, 167
2,830,718
9,659,885
19 Rol•t•d party transactkn
Thefe **re no ￿laled party transartk)ns durlre the yeaf {2024'. £NI).
20 Controlllni lrtertst
The charlty Is controlled by the trustees.
27